Alnylam Pharmaceuticals
ALNY
#650
Rank
A$54.20 B
Marketcap
A$405.96
Share price
0.68%
Change (1 day)
-2.80%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company